Sissetulev kiriAvalik
Euroopa farmakopöa monograafia asjus
Ravimiamet · 14. mai 2025
- Viit
- REP-1/2475-1
- Registreeritud
- 14. mai 2025
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2025
- Vastutaja
- Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)
Sisu (failidest)
Signe Leito
Saatja: [email protected]
Saatmisaeg: kolmapäev, 14. mai 2025 17:00
Adressaat: Signe Leito
Teema: Survey for information on approved products containing difloxacin hydrochloride trihydrate for veterinary use - Group 10A:
EDQM-2025-02040-mail
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Please make sure to include in any reply our mail reference: EDQM-2025-02040-mail
****************************************************************************
European Pharmacopoeia Commission Secretariat
RZ/PH/ 2025-02041L Strasbourg, 14 May 2025
JSB/mk
LETTER FOR THE ATTENTION OF NPAs
Copy: Presidium
Dear Colleagues,
Please find below the link to an enquiry for information on approved products containing difloxacin hydrochloride trihydrate for veterinary use (2239), as
well as other forms of difloxacin.
https://survey.edqm.eu/index.php?r=survey/index&sid=157693&lang=en
In order to have access to the enquiry, please copy and paste the link into your Internet browser.
Deadline for replies: 3 June 2025.
1
Best regards,
On behalf of Dr Jaume Sanz-Biset
Mireille Kopf
Secretarial Assistant
European Pharmacopoeia Department
EDQM - Council of Europe
Tel.: +33 (0)3 88 41 28 53 / Fax: +33 (0)3 88 41 27 71
****************************************************************************
Please make sure to include in any reply our mail reference: EDQM-2025-02040-mail
2